Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 18.24
- Piotroski Score 4.00
- Grade Buy
- Symbol (DXR)
- Company Daxor Corporation
- Price $9.26
- Changes Percentage (6.52%)
- Change $0.55
- Day Low $8.54
- Day High $9.26
- Year High $10.04
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
- Last Earnings 12/21/2017
- Ex-Dividend for 5/16 Dividend 01/05/2018
- Dividend Payable 01/12/2018
- Today N/A
- Next Earnings (Estimated) 02/27/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.14
- Trailing P/E Ratio 64.64
- Forward P/E Ratio 64.64
- P/E Growth 64.64
- Net Income $280,640
